EDGAR Filing Documents for 0000885590-13-000025

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000885590-13-000025

Filing Date

2013-05-03

Accepted

2013-05-03 12:32:34

Documents

Period of Report

2013-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	valeantq12013.htm	10-Q	1769492
2	EXHIBIT 4.1	exhibit41.htm	EX-4.1	31193
3	EXHIBIT 4.2	exhibit42.htm	EX-4.2	30477
4	EXHIBIT 4.3	exhibit43.htm	EX-4.3	31089
5	EXHIBIT 4.4	exhibit44.htm	EX-4.4	31003
6	EXHIBIT 4.5	exhibit45.htm	EX-4.5	31716
7	EXHIBIT 4.6	exhibit46.htm	EX-4.6	30254
8	EXHIBIT 31.1	exhibit311.htm	EX-31.1	14675
9	EXHIBIT 31.2	exhibit312.htm	EX-31.2	14629
10	EXHIBIT 32.1	exhibit321.htm	EX-32.1	8808
11	EXHIBIT 32.2	exhibit322.htm	EX-32.2	8741
	Complete submission text file	0000885590-13-000025.txt		19361436

Data Files

Seq	Description	Document	Type	Size
12	EXHIBIT 101.INS	vrx-20130331.xml	EX-101.INS	2455571
13	EXHIBIT 101.SCH	vrx-20130331.xsd	EX-101.SCH	253175
14	EXHIBIT 101.CAL	vrx-20130331_cal.xml	EX-101.CAL	141779
15	EXHIBIT 101.LAB	vrx-20130331_lab.xml	EX-101.LAB	3529421
16	EXHIBIT 101.PRE	vrx-20130331_pre.xml	EX-101.PRE	1749659
17	EXHIBIT 101.DEF	vrx-20130331_def.xml	EX-101.DEF	1290343

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)